The IASLC Staging Project: 9th Edition TNM | IASLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests preview the publication of the IASLC Ninth Edition of Tumor, Node, and Metastasis (TN …
Related Articles
Clinical Chief – Cellular Therapy (ACT) – Medical Oncology
Title: Clinical Chief – Cellular Therapy (ACT) – Medical Oncology Job Type: Regular Company: Roswell Park Comprehensive Cancer Center Department: Department of Medicine – Lymphoma…
Preprint Servers have Repeatedly Censored our Work on COVID-19 Policy
MedRxiv, SSRN have repeatedly taken down or blocked preprints on articles critical of the CDC, masks, or vaccine mandates
Tumor-Infiltrating Lymphocytes Therapy Now Available for Treating Unresectable or Metastatic Melanoma
When the FDA granted accelerated approval of tumor-infiltrating lymphocyte (TIL) treatment with lifileucel for patients with metastatic melanoma, Cleveland Clinic Cancer Institute was one of…
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) shows statistically significant and clinically meaningful improvement in overall survival versus osimertinib
Median overall survival improvement expected to exceed one year First and only regimen with a survival benefit over current standard of care in first-line treatment…
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
Key PointsDexamethasone dose reductions <40 to 60 mg weekly are common in multiple myeloma, even for patients enrolled on clinical trials.In our large a
A Hero’s Journey: With Guests Ethan Gilsdorf, David Fajgenbaum & Kurt Gray
Framing the narrative of your life as an epic journey can give you control and meaning.
They may be ‘miracle’ drugs, but obesity meds call for a team approach
The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single physician to handle.
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
